In the latest trading session,, 0.47 million Metagenomi Inc (NASDAQ:MGX) shares changed hands as the company’s beta touched -0.35. With the company’s most recent per share price at $2.24 changing hands around $0.25 or 12.36% at last look, the market valuation stands at $83.59M. MGX’s current price is a discount, trading about -127.68% off its 52-week high of $5.10. The share price had its 52-week low at $1.23, which suggests the last value was 45.09% up since then. When we look at Metagenomi Inc’s average trading volume, we note the 10-day average is 1.05 million shares, with the 3-month average coming to 556.89K.
Analysts gave the Metagenomi Inc (MGX) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.33. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended MGX as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight. Metagenomi Inc’s EPS for the current quarter is expected to be -0.61.
Metagenomi Inc (NASDAQ:MGX) trade information
Instantly MGX is in green as seen in intraday trades today. With action -0.62%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -56.83%, with the 5-day performance at -0.62% in the red. However, in the 30-day time frame, Metagenomi Inc (NASDAQ:MGX) is 51.08% up. Looking at the short shares, we see there were 2.1 million shares sold at short interest cover period of 5.57 days.
The consensus price target for the stock as assigned by Wall Street analysts is 14.5, meaning bulls need an upside of 84.55% from its recent market value. According to analyst projections, MGX’s forecast low is 7 with 22 as the target high. To hit the forecast high, the stock’s price needs a -882.14% plunge from its current level, while the stock would need to soar -212.5% for it to hit the projected low.
Metagenomi Inc (MGX) estimates and forecasts
Year-over-year growth is forecast to reach -41.71% down from the last financial year.
Consensus estimates given by 5 financial analysts project the company’s revenue in the current quarter to hit an average of 7.72M. 5 analysts are of the opinion that Metagenomi Inc’s revenue for the current quarter will be 7.92M. The company’s revenue for the corresponding quarters a year ago was 20.01M. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -61.42%. The estimates for the next quarter sales put growth at 0.00%.
The 2025 estimates are for Metagenomi Inc earnings to decrease by -3.60%, but the outlook for the next 5-year period is at -14.66% per year.
MGX Dividends
Metagenomi Inc is expected to release its next quarterly earnings report on 2025-May-13.
Metagenomi Inc (NASDAQ:MGX)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 28.20% of Metagenomi Inc shares while 26.49% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 36.90%. There are 26.49% institutions holding the Metagenomi Inc stock share, with NOVO HOLDINGS A/S the top institutional holder. As of 2024-06-30, the company held 4.9146% of the shares, roughly 1.8 million MGX shares worth $7.34 million.
RA CAPITAL MANAGEMENT, L.P. holds the second largest percentage of outstanding shares, with 4.0348% or 1.48 million shares worth $6.03 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . With 760.0 shares estimated at $1.7 million under it, the former controlled 2.03% of total outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held about 1.74% of the shares, roughly 650.35 shares worth around $1.46 million.
